haemophilia

News

Spark and Pfizer’s gene therapy wows in haemophilia B

Gene therapy company Spark Therapeutics has published data showing its one-time treatment can almost entirely eliminate bleeds in patients with haemophilia B.

News

Roche double trial success could expand use of two new drugs

A double trial success from Roche sees it eyeing a combination therapy in lucrative first-line lung cancer, and wider use of its just-approved haemophilia drug, Hemlibra.

News

FDA approves Roche potential haemophilia blockbuster

Blood cancer drug Gazyva also gets new US use

News

A gamechanger in haemophilia? SOBI unruffled by Roche's impe...

The received wisdom is that a generation of new products in haemophilia A, led by Roche’s emicizumab and potentially curative gene therapies, will bring about a transformation of treatment

News